rs754264874
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM5
The NM_000384.3(APOB):c.10519C>T(p.Arg3507Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,613,842 control chromosomes in the GnomAD database, with no homozygous occurrence. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3507P) has been classified as Pathogenic.
Frequency
Consequence
NM_000384.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOB | NM_000384.3 | c.10519C>T | p.Arg3507Trp | missense_variant | 26/29 | ENST00000233242.5 | NP_000375.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOB | ENST00000233242.5 | c.10519C>T | p.Arg3507Trp | missense_variant | 26/29 | 1 | NM_000384.3 | ENSP00000233242.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152132Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250624Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135442
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461710Hom.: 0 Cov.: 36 AF XY: 0.00000688 AC XY: 5AN XY: 727158
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152132Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74318
ClinVar
Submissions by phenotype
Hypercholesterolemia, autosomal dominant, type B Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine | Sep 26, 2019 | The c.10519C>T (p.Arg3507Trp) variant in the APOB gene has been reported in an individual with mild to moderate hypercholesterolemia (PMID: 11115503) and in Dutch patients with FH (PMID: 16250003). Also known as p.Arg3480Trp, functional studies showed that this variant reduced the binding of LDL to the LDL receptor (PMID: 11115503). This variant is observed at a frequency of 6/282024 in the gnomAD population database. A different missense change at the same amino acid, p.Arg3507Pro, has also been reported in individuals with hypercholesterolemia (PMID: 7882518, 16250003). In light of the currently available data this c.10519C>T (p.Arg3507Trp) variant is classified as likely pathogenic. - |
Hypercholesterolemia, familial, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | curation;literature only | Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge | Mar 01, 2016 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 17, 2024 | The p.R3507W variant (also known as c.10519C>T), located in coding exon 26 of the APOB gene, results from a C to T substitution at nucleotide position 10519. The arginine at codon 3507 is replaced by tryptophan, an amino acid with dissimilar properties. This variant (also referred to as p.R3480W) has been detected in individuals with hypercholesterolemia or premature coronary artery disease; however, this variant has also been detected in an individual reported to have features of hypobetalipoproteinemia (Borén J et al. J Biol Chem, 2001 Mar;276:9214-8; Benn M et al. J Biol Chem, 2005 Jun;280:21052-60; Murdock DR et al. Genet Med, 2021 Dec;23:2404-2414). Functional studies suggest this variant may alter protein function; however, additional evidence is needed to confirm this finding (Borén J et al. J Biol Chem, 2001 Mar;276:9214-8; Benn M et al. J Biol Chem, 2005 Jun;280:21052-60). This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 03, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at